Sareum (SAR.L) traded down -40 % during a 24 hours period ending at 05:36 AM Central Europe on Wednesday 28th. One Sareum stock can currently be bought for about GBX 16.25 on popular exchanges. Current supply of Sareum stocks is 1.4 mn. Sareum has a current market capitalization of GBX 31.5 mn and approximately GBX 60.5 mn worth of Sareum was traded on exchanges in the last 24 hours. Since last month end, Sareum has traded -45.9 % down. Simple moving average of last 200 days is at GBX 21.59. The highest price of past 52 weeks was recorded at GBX 40 on 08/26/2026. 52 weeks low was at GBX 0.28 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Cardiff Property (CDFF.L) traded flat 0 % and now trades at GBX 2,750. Cardiff Property has a market capitalisation of GBX 36.3 mn. Cardiff Property has a current price to earnings ratio of 20.72.
Mission (TMG.L) traded up 5.16 % and now trades at GBX 27. Mission has a market capitalisation of GBX 33.2 mn.
European Green Transition Pl (EGT.L) traded down -2.44 % and now trades at GBX 10. Current market capitalisation for European Green Transition Pl is GBX 37 mn.
Kavango (KAV.L) traded flat 0 % and now trades at GBX 0.62. Kavango has a market capitalisation of GBX 37.2 mn.
Xp Factory (XPF.L) traded up 0.34 % and now trades at GBX 14.75. Xp Factory has a market capitalisation of GBX 35.3 mn.
About Sareum
Sareum Holdings PLC is a health care company with its base in Cambridge, United Kingdom. The company specializes in the discovery and development of therapeutic drugs to treat cancer and autoimmune diseases. Their product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2 kinase. Sareum collaborates with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The IPO of the company took place on 11th October 2004.